Solasia Pharma K.K. (TSE : 4597) acquired Episil oral liquid business from Camurus AB (OM : CAMX).
Solasia Pharma K.K. (TSE : 4597) completed the acquisition of Episil oral liquid business from Camurus AB (publ) (OM : CAMX) on July 8, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28 JPY | +3.70% | +7.69% | -37.78% |
1st Jan change | Capi. | |
---|---|---|
-37.78% | 31.47M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.92% | 32.81B | |
+54.31% | 25B | |
-16.51% | 15.29B | |
-8.27% | 12.93B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+3.75% | 8.98B |